A malignant neoplasm of the colon is the medical term for colon cancer. You’ll often see this phrase on pathology reports, billing codes, or medical records. It means that cells in the lining of the colon (the longest part of the large intestine) have grown out of control, forming a cancerous tumor that can invade nearby tissue and potentially spread to other parts of the body. This distinguishes it from benign (non-cancerous) growths like polyps, which are small pieces of bulging tissue that stay contained and don’t invade surrounding structures.
How Colon Cancer Develops
Most colon cancers begin as polyps, small growths on the inner wall of the colon. Not all polyps become cancerous, but certain types carry more risk. High-risk adenomas, those 1 centimeter or larger or containing abnormal-looking cells, are the ones most likely to transform into cancer over time. This process typically takes years, which is why removing polyps during a colonoscopy is one of the most effective ways to prevent colon cancer from developing in the first place.
The vast majority of colon cancers are adenocarcinomas, meaning they start in the gland cells that produce mucus to lubricate the inside of the colon. When a pathology report says “malignant neoplasm of the colon,” it almost always refers to this type. Less common subtypes include mucinous adenocarcinoma (10 to 20% of cases), serrated adenocarcinoma (8 to 10%), and rarer forms like signet-ring cell carcinoma (about 1%) and neuroendocrine carcinoma (less than 1%). The subtype matters because some behave more aggressively than others and respond differently to treatment.
Symptoms to Recognize
Colon cancer and precancerous polyps often cause no symptoms early on, which is why screening matters so much. When symptoms do appear, they tend to include:
- Changes in bowel habits that persist, such as new diarrhea or constipation
- Blood in or on your stool, which may appear bright red or very dark
- A feeling that your bowel doesn’t empty completely
- Persistent abdominal pain, aches, or cramps that don’t resolve
- Unexplained weight loss
None of these symptoms are unique to colon cancer. Many other conditions cause similar problems. But symptoms that last more than a few weeks, especially blood in the stool combined with a change in bowel habits, warrant investigation.
Risk Factors
Some risk factors for colon cancer are beyond your control. Inherited genetic conditions like Lynch syndrome significantly raise the odds, as does a personal or family history of colorectal polyps or cancer. Risk also increases with age, though cases in younger adults have been rising.
Diet plays a major role, particularly for younger patients. A Cleveland Clinic study identified diet-derived molecules associated with red and processed meat consumption as key drivers of young-onset colorectal cancer risk. Younger colon cancer patients had higher levels of metabolites linked to red meat digestion compared to older patients, suggesting that long-term dietary patterns established early in life may set the stage for cancer decades later. Other modifiable risk factors include obesity, physical inactivity, smoking, and heavy alcohol use.
How Colon Cancer Is Staged
If a malignant neoplasm is confirmed, the next step is determining how far it has spread. Staging uses three factors: how deeply the tumor has grown into the colon wall, whether cancer cells have reached nearby lymph nodes, and whether the cancer has spread to distant organs like the liver or lungs.
In practical terms, a tumor confined to the inner layers of the colon wall is early-stage. Once it grows through the full thickness of the wall or reaches lymph nodes, it’s considered more advanced. Cancer that has traveled to distant organs is classified as metastatic, or stage IV. The stage at diagnosis is the single biggest factor in determining outlook and treatment options.
Survival Rates by Stage
Five-year relative survival rates for colorectal cancer, based on SEER data from 2016 to 2022, show a clear picture of why early detection matters. When the cancer is localized, meaning it hasn’t spread beyond the colon, the five-year survival rate is 91.3%. For regional disease, where cancer has reached nearby lymph nodes, that number drops to 75.2%. Once the cancer has metastasized to distant organs, the five-year survival rate falls to 16.9%.
These are population-level averages. Individual outcomes depend on the tumor’s specific biology, how well it responds to treatment, and the patient’s overall health.
Treatment Options
Surgery is the primary treatment for colon cancer that hasn’t spread widely. The standard approach involves removing the section of colon containing the tumor along with nearby lymph nodes, then reconnecting the healthy ends. This can be done through traditional open surgery or through a less invasive laparoscopic approach, which generally means a shorter hospital stay and faster recovery. Very early cancers found in a polyp can sometimes be treated by simply removing the polyp during a colonoscopy.
For cancers that have reached lymph nodes, chemotherapy after surgery reduces the chance of recurrence. Common regimens combine a fluoropyrimidine (a drug that interferes with cancer cell growth) with a platinum-based agent. Treatment typically lasts three to six months depending on the regimen and how advanced the cancer was.
Advanced or metastatic colon cancer is treated with chemotherapy combined with targeted therapies. These targeted drugs work by blocking specific signals that cancer cells use to grow and spread, such as blood vessel growth signals or growth factor receptors on the tumor surface. In some cases, isolated metastases in the liver or lungs can be surgically removed, which can significantly improve outcomes for selected patients.
Immunotherapy has become an option for a specific subset of colon cancers that have a feature called microsatellite instability, meaning the tumor’s DNA repair system is defective. These tumors respond well to immune checkpoint inhibitors, which help the body’s own immune system recognize and attack cancer cells. For patients whose tumors have this feature, immunotherapy can be remarkably effective, sometimes used as the first-line treatment.
Screening Recommendations
The U.S. Preventive Services Task Force recommends that most adults begin screening for colorectal cancer at age 45 and continue through age 75. For people at average risk with no family history or other risk factors, a colonoscopy every 10 years is the standard interval. If polyps are found, your doctor will recommend more frequent follow-up based on the number, size, and type of polyps removed.
People with a family history of colon cancer or inherited genetic syndromes typically need to start screening earlier and at shorter intervals. Screening is one of the few cancer prevention tools that can actually catch the disease before it starts, since removing precancerous polyps eliminates the chance of those polyps ever becoming malignant.